八部门印发《中药工业高质量发展实施方案（2026-2030年）》

Core Viewpoint - The "Implementation Plan for High-Quality Development of Traditional Chinese Medicine Industry (2026-2030)" aims to establish a collaborative development system for the entire industry chain of traditional Chinese medicine by 2030, enhancing supply capabilities, digitalization, and green transformation while fostering innovation and quality management [1][3]. Overall Requirements - The plan is guided by Xi Jinping's thoughts and aims to optimize the structure and promote the transformation of the traditional Chinese medicine industry, enhancing resilience and stability in the supply chain [2]. Key Tasks - Raw Material Quality Improvement and Stable Supply: Establish high-standard production bases for key raw materials, enhance initial processing levels, and improve quality standards [4][5]. - Collaborative Innovation: Strengthen the collaborative innovation system by integrating resources from various sectors to address technological bottlenecks in the industry [6][7]. - Manufacturing Capability Enhancement: Focus on improving the production standards for traditional Chinese medicine pieces and promoting digital and green technologies in manufacturing [8][9]. National Drug Industry Revitalization - Emphasize the development of ethnic medicine resources and modernize the ethnic drug industry through comprehensive planning and support policies [10][11]. Promotion of Traditional Chinese Medicine Products - Encourage the creation of high-quality traditional Chinese medicine products and enhance market presence through branding and consumer engagement strategies [12][13]. Cultivation of Excellent Enterprises - Foster a competitive market environment to stimulate innovation and support the establishment of leading enterprises in the traditional Chinese medicine sector [14][15].